Search results for "PPAR"

showing 10 items of 1686 documents

Fixed But Not Autoadjusting Positive Airway Pressure Attenuates the Time-dependent Decline in Glomerular Filtration Rate in Patients With OSA

2018

Abstract: BACKGROUND: The impact of treating OSA on renal function decline is controversial. Previous studies usually included small samples and did not consider specific effects of different CPAP modalities. The aim of this study was to evaluate the respective influence of fixed and autoadjusting CPAP modes on estimated glomerular filtration rate (eGFR) in a large sample of patients derived from the prospective European Sleep Apnea Database cohort. METHODS: In patients of the European Sleep Apnea Database, eGFR prior to and after follow-up was calculated by using the Chronic Kidney Disease-Epidemiology Collaboration equation. Three study groups were investigated: untreated patients (n = 14…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyUrologyRenal functionSettore MED/10 - Malattie Dell'Apparato RespiratorioEgfr declineCritical Care and Intensive Care MedicineOSA03 medical and health sciences0302 clinical medicinePositive airway pressuremedicineautomatic CPAPIn patientKidneyglomerular filtration ratetherapybusiness.industrySleep apneafixed CPAPta3121medicine.diseaserespiratory tract diseasesLarge samplemedicine.anatomical_structure030228 respiratory systemCohortHuman medicinebusinessCardiology and Cardiovascular Medicine030217 neurology & neurosurgery
researchProduct

Advances in asthma pathophysiology: stepping forward from the Maurizio Vignola experience

2015

Maurizio Vignola was a superb and innovative researcher, who wrote seminal papers on the biology of airway epithelium in asthma. Inflammation and remodelling were the main topics of his research, mostly conducted in biopsy specimens from patients with asthma of variable severity, encompassing the entire spectrum of the disease from mild to severe asthma. His observations contributed to define the biology of asthma as we know it today, and opened the way to the personalised treatment of asthma. His group has successfully continued to investigate the biology and clinical aspects of bronchial asthma, with major interest in the clinical use of biomarkers to monitor disease activity, and in the …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyVariable severityAsthma phenotypesSevere asthmaDrug ResistanceMEDLINEDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioAdrenal Cortex HormoneDisease activityGlucocorticoidAdrenal Cortex Hormonesimmune system diseasesmedicineHumansIntensive care medicineGlucocorticoidsAsthmalcsh:RC705-779Inflammationbusiness.industrylcsh:Diseases of the respiratory systemBiomarkermedicine.diseaseAsthmarespiratory tract diseasesPhysical therapyAirway RemodelingTreatment strategybusinessBiomarkersHumanEuropean Respiratory Review
researchProduct

Assessing and accessing the small airways; implications for asthma management

2013

Despite the wealth of experience in the management of asthma, the disease remains inadequately controlled in some patients, who face long-term respiratory impairment and disability. The disease has been characterised as an inflammatory condition affecting first the larger airways and eventually the smaller airways, but there is evidence that peripheral airway involvement defines a particular and more severe phenotype of asthma. For this reason, assessing functional and biological parameters reflective of small airways involvement is important prognostically. No assessment method is universally and directly representative of peripheral airway function, but the traditional spirometric tests, …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyVital capacityVital CapacityDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioAsthma managementAir trappingNitric OxideNitric Oxide; Respiratory Function Tests; Vital Capacity; Humans; Tomography X-Ray Computed; Asthma; Forced Expiratory Volume; Breath TestsForced Expiratory VolumeMedicineHumansPharmacology (medical)Intensive care medicineAsthmaRespiratory Function Testbusiness.industrySmall airwaysBiochemistry (medical)medicine.diseaseResponse to treatmentAsthmarespiratory tract diseasesRespiratory Function TestsImpulse OscillometryBreath TestsAnesthesiamedicine.symptombusinessTomography X-Ray ComputedHuman
researchProduct

Metabolic aspects of obstructive sleep apnoea syndrome.

2009

Insulin resistance is often associated with obstructive sleep apnoea syndrome (OSAS) and could contribute to cardiovascular risk in OSAS. Sleep loss and intermittent hypoxia could contribute to the pathogenesis of the metabolic alterations associated with obesity, a common feature of OSAS. The biology of the adipocyte is being increasingly studied, and it has been found that hypoxia negatively affects adipocyte function. In November 2007, the European Respiratory Society and two EU COST Actions (Cardiovascular risk in OSAS (B26) and Adipose tissue and the metabolic syndrome (BM0602)), held a Research Seminar in Du¨sseldorf, Germany, to discuss the following: 1) the effects of hypoxia on glu…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryAdipose tissueIntermittent hypoxiaInflammationHypoxia (medical)Settore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.diseaseObesitynervous system diseasesrespiratory tract diseaseschemistry.chemical_compoundEndocrinologyInsulin resistancestomatognathic systemchemistryAdipokines adipose tissue inflammation insulin resistance hypoxia treatmentAdipocyteInternal medicinemedicinemedicine.symptomMetabolic syndromebusiness
researchProduct

Corrigendum to “Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?” [YPUPT 31C (2015) 63–67]

2015

NA

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryInhalerBiochemistry (medical)MedicinePharmacology (medical)asthmaSettore MED/10 - Malattie Dell'Apparato RespiratorioRespiratory systembusinessIntensive care medicineAffect (psychology)Pulmonary Pharmacology & Therapeutics
researchProduct

The Contribution of Small-Airway Abnormalities in Chronic Obstructive Pulmonary Disease Clinical Manifestations: More than a Functional Issue.

2016

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryMEDLINESocio-culturalePulmonary diseaseSettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineText mining030228 respiratory systemAirway abnormalitiesmedicineHumans030212 general & internal medicineIntensive care medicinebusinessHumanRespiration; international review of thoracic diseases
researchProduct

Clinical physiology and sleep: insights from the European Respiratory Society Congress 2017.

2017

The 2017 Annual Congress of the European Respiratory Society (ERS) held in Milan has featured the latest research on clinical physiology and sleep.

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryeducationMEDLINEPhysiologysocial sciencesReview ArticleSettore MED/10 - Malattie Dell'Apparato RespiratorioSleep in non-human animalsClinical PhysiologymedicineRespiratory systemIntensive care medicinebusinesshealth care economics and organizationssleep clinical physiology cancerJournal of thoracic disease
researchProduct

Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma

2021

INTRODUCTION Asthma symptoms can be relieved through a maintenance treatment combining long-acting β2-agonist and inhaled corticosteroids (LABA/ICS). However, for patients with inadequately controlled asthma, the LABA/ICS combination might not be sufficient. Under these conditions, clinical guidelines recommend the administration of inhaled long-acting muscarinic antagonists (LAMA) as an add-on therapy to LABA/ICS to better control asthma and improve lung function. For nearly two decades, the only LAMA to be approved on the market has been tiotropium. AREAS COVERED We reviewed recent clinical studies evaluating the safety and efficacy of LABA/LAMA/ICS fixed dose combinations by searching Pu…

Pulmonary and Respiratory Medicinemedicine.medical_specialtycorticosteroidFixed-dose combinationLABAAsthma corticosteroid fixed dose combination ICS inhaler LABA LAMA once daily combination uncontrolled asthmaMuscarinic Antagonistsonce daily combinationQuinolonesSettore MED/10 - Malattie Dell'Apparato RespiratorioinhalerAdrenal Cortex HormonesInternal medicineAdministration InhalationImmunology and AllergyMedicineHumansfixed dose combinationAdrenergic beta-2 Receptor AgonistsAsthmaFluticasonebiologyInhalationuncontrolled asthmabusiness.industryInhalerPublic Health Environmental and Occupational HealthLAMALamamedicine.diseasebiology.organism_classificationGlycopyrrolateFluticasone-Salmeterol Drug CombinationAsthmarespiratory tract diseasesDrug CombinationsICSIndansIndacaterolSalmeterolbusinessMometasone Furoatehormones hormone substitutes and hormone antagonistsmedicine.drug
researchProduct

A Case of Severe Dyspnea and an Unusual Bronchoscopy: The Chilaiditi Syndrome

2006

Pulmonary and Respiratory Medicinemedicine.medical_specialtymedicine.diagnostic_testColonbusiness.industryDiaphragmRespiratory diseaseChilaiditi syndromeSettore MED/10 - Malattie Dell'Apparato RespiratorioMiddle Agedmedicine.diseaseSurgeryEndoscopyDiaphragm (structural system)RadiographyDyspneaLiverBronchoscopyBronchoscopymedicineHumansFemaleChilaiditi Syndrome bronchoscopybusinessColonic diseaseRespiration
researchProduct

The use of bronchodilators in the treatment of airway obstruction in elderly patients

2006

Abstract Ageing is associated with important anatomical, physiological and psychosocial changes that may have an impact on the management of obstructive airway diseases (asthma and chronic obstructive pulmonary disease (COPD)) and on their optimal therapy. Ageing-related modifications might be responsible for a different effectiveness of bronchodilators in the elderly patients as compared to younger subjects. Furthermore, the physiological involution of organs and the frequent comorbidity, often interfere with pharmacokinetics of bronchodilator drugs used in asthma and COPD. This review will focus on the use of bronchodilators in the elderly, with particular attention to the achievable goal…

Pulmonary and Respiratory Medicinemedicine.medical_specialtymedicine.drug_classSettore MED/10 - Malattie Dell'Apparato RespiratorioCholinergic AntagonistsPulmonary Disease Chronic ObstructiveElderlyBronchodilatorasthma COPDmedicineHumansPharmacology (medical)Intensive care medicineAdverse effectAsthmaAgedCOPDbusiness.industryBiochemistry (medical)Airway obstructionAdrenergic beta-Agonistsmedicine.diseaseComorbidityrespiratory tract diseasesBronchodilator AgentsbronchodilatorsAirway ObstructionBronchodilator AgentsXanthinesAirwaybusiness
researchProduct